ADO 0.00% 2.1¢ anteotech ltd

Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-23

  1. 2,256 Posts.
    lightbulb Created with Sketch. 416
    Nothing good I wouldn't think buggalugs.

    Looks like the company can forget about any income from POC sales for the foreseeable future.

    https://hotcopper.com.au/data/attachments/4803/4803805-b27456cbfeb428d2a2e9eddac31b0e8f.jpg




 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.